COVID-19 infection: an overview on cytokine storm and related interventions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 infection: an overview on cytokine storm and related interventions
Authors
Keywords
-
Journal
Virology Journal
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-26
DOI
10.1186/s12985-022-01814-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases
- (2021) Giulio Cavalli et al. AUTOIMMUNITY REVIEWS
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- (2021) Stephany Beyerstedt et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy of canakinumab in mild or severe COVID‐19 pneumonia
- (2021) Falasca Katia et al. Immunity Inflammation and Disease
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
- (2021) Dounia Darif et al. MICROBIAL PATHOGENESIS
- Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
- (2021) Serena Patel et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapeutic targeting of IL-6 trans-signaling
- (2021) Stefan Rose-John CYTOKINE
- Interleukin‐17—A multifaceted cytokine in viral infections
- (2021) Utkarsha Sahu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures
- (2020) Yixuan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients
- (2020) Clément Saccheri et al. Annals of Intensive Care
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- COVID-19 Autopsies, Oklahoma, USA
- (2020) Lisa M Barton et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- (2020) Federica Raucci et al. AUTOIMMUNITY REVIEWS
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
- (2020) Serena Colafrancesco et al. AUTOIMMUNITY REVIEWS
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
- (2020) Gaurav Aggarwal et al. CURRENT PROBLEMS IN CARDIOLOGY
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis
- (2020) Jieyun Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- COVID‐19 pneumonia treated with Sarilumab: a clinical series of eight patients
- (2020) Maurizio Benucci et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- ADAM17 inhibition may exert a protective effect on COVID-19
- (2020) Vanesa Palau et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
- (2020) Sasmita Poudel Adhikari et al. Infectious Diseases of Poverty
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Potential role of IL‐17 blocking agents in the treatment of severe COVID‐19?
- (2020) Vedrana Bulat et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1
- (2020) Leonard H. Calabrese et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- The cytokine storm of COVID-19: a spotlight on prevention and protection
- (2020) Lucie Pearce et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
- (2020) Lorenzo M. Canziani et al. JOURNAL OF AUTOIMMUNITY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- May IL-17 have a role in COVID-19 infection?
- (2020) Matteo Megna et al. MEDICAL HYPOTHESES
- Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
- (2020) Ghazal Aghagoli et al. Neurocritical Care
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Preliminary predictive criteria for COVID-19 cytokine storm
- (2020) Roberto Caricchio et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphopenia during the COVID-19 infection: What it shows and what can be learned
- (2020) Soheil Tavakolpour et al. IMMUNOLOGY LETTERS
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- Cytokines and COVID-19: friends or foes?
- (2020) Mohsen Rokni et al. Human Vaccines & Immunotherapeutics
- Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
- (2020) Antonella Fara et al. Open Biology
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
- (2020) Tewodros Shibabaw Journal of Inflammation Research
- A comprehensive review on sarilumab in COVID-19
- (2020) Sajad Khiali et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study
- (2020) Daniele Generali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pathophysiology of COVID-19-associated acute respiratory distress syndrome – Authors' reply
- (2020) Giacomo Grasselli et al. Lancet Respiratory Medicine
- Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
- (2020) A. Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin
- (2019) Laura C. Burzynski et al. IMMUNITY
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- The protective and pathogenic roles of IL-17 in viral infections: friend or foe?
- (2019) Wen-Tao Ma et al. Open Biology
- ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
- (2019) Schumacher et al. Cancers
- Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
- (2018) Janette Bester et al. CYTOKINE
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Anakinra for the treatment of rheumatoid arthritis: a safety evaluation
- (2018) Julio Ramírez et al. Expert Opinion On Drug Safety
- A review of sarilumab for the treatment of rheumatoid arthritis
- (2018) Eun Bong Lee Immunotherapy
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- IL-6: a cytokine at the crossroads of autoimmunity
- (2018) Britta E Jones et al. CURRENT OPINION IN IMMUNOLOGY
- The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders
- (2018) Kuo-Chen Wu et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis
- (2017) S.-C. Bae et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
- (2015) A. Deisseroth et al. CLINICAL CANCER RESEARCH
- Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
- (2015) Marine Lacroix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β
- (2015) Jean-Michel Rondeau et al. mAbs
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Clinical Development of Siltuximab
- (2015) Christine C. Davis et al. Current Oncology Reports
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- T Cell Responses to Whole SARS Coronavirus in Humans
- (2014) C. K.-f. Li et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function
- (2014) W. Hou et al. JOURNAL OF VIROLOGY
- RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway
- (2014) Xiaqiong Wang et al. NATURE IMMUNOLOGY
- Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
- (2013) Yue Zheng et al. IMMUNITY
- IL-17 cytokines in immunity and inflammation
- (2013) Wei Jin et al. Emerging Microbes & Infections
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
- (2011) Markus F. Neurath et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
- (2011) Toshio Tanaka et al. FEBS LETTERS
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started